Autonomix Medical, Inc.
AMIX
$5.37
$0.101.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 35.20% | 44.12% | 49.85% | 40.20% | 5.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.68% | 47.01% | 63.23% | 55.13% | 30.98% |
| Operating Income | -33.68% | -47.01% | -63.23% | -55.13% | -30.98% |
| Income Before Tax | -33.69% | -46.51% | -26.52% | -18.99% | 30.20% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33.69% | -46.51% | -26.52% | -18.99% | 30.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.69% | -46.51% | -26.52% | -18.99% | 30.20% |
| EBIT | -33.68% | -47.01% | -63.23% | -55.13% | -30.98% |
| EBITDA | -35.16% | -49.26% | -65.48% | -56.30% | -51.56% |
| EPS Basic | 62.96% | 56.96% | 62.41% | 58.33% | 68.03% |
| Normalized Basic EPS | 62.96% | 56.96% | 62.41% | 58.33% | 68.03% |
| EPS Diluted | 62.96% | 56.96% | 62.41% | 58.33% | 68.03% |
| Normalized Diluted EPS | 62.96% | 56.96% | 62.41% | 58.33% | 68.03% |
| Average Basic Shares Outstanding | 316.11% | 307.94% | 268.98% | 182.48% | 118.11% |
| Average Diluted Shares Outstanding | 316.11% | 307.94% | 268.98% | 182.48% | 118.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |